BIOREGENX, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOREGENX, INC. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $527.09K.
- BIOREGENX, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $63.21K.
- BIOREGENX, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $414.11K.
- BIOREGENX, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $337.74K.
- BIOREGENX, INC. stock issued during period, value, new issues for fiscal 2023 was $1.34M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $527.09K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-04-16 | $1.34M 10-K/A · filed 2025-04-16 |
| 2023-09-30 | $63.21K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $414.11K 10-Q · filed 2024-10-09 | |
| 2023-03-31 | $337.74K 10-Q/A · filed 2024-10-09 |